tiprankstipranks
Advertisement
Advertisement

NXTC Stock Latest News

NextCure Shareholders Approve Expanded Omnibus Incentive Plan
Company AnnouncementsNextCure Shareholders Approve Expanded Omnibus Incentive Plan
18d ago
8K
NXTC
NextCure share weakness overdone, says Lucid Capital
PremiumThe Fly
NextCure share weakness overdone, says Lucid Capital
1M ago
NXTC
NextCure presents Phase 1 data for SIM0505 in gynecologic cancers
PremiumThe Fly
NextCure presents Phase 1 data for SIM0505 in gynecologic cancers
1M ago
NXTC
NextCure Reports Positive SIM0505 Phase 1 Gynecologic Cancer Data
PremiumCompany Announcements
NextCure Reports Positive SIM0505 Phase 1 Gynecologic Cancer Data
1M ago
8K
NXTC
NextCure initiated with a Buy at Lucid Capital
PremiumThe Fly
NextCure initiated with a Buy at Lucid Capital
2M ago
NXTC
NextCure reports Q1 EPS ($1.87), consensus ($2.03)
PremiumThe FlyNextCure reports Q1 EPS ($1.87), consensus ($2.03)
2M ago
NXTC
NextCure initiates dose optimization portion of SIM0505 study
Premium
The Fly
NextCure initiates dose optimization portion of SIM0505 study
2M ago
NXTC
NextCure granted Fast Track Designation for SIM0505 by FDA
Premium
The Fly
NextCure granted Fast Track Designation for SIM0505 by FDA
3M ago
NXTC
NextCure trading resumes
PremiumThe Fly
NextCure trading resumes
4M ago
NXTC
NextCure trading halted, volatility trading pause
PremiumThe Fly
NextCure trading halted, volatility trading pause
4M ago
NXTC
NextCure Updates ADC Pipeline Progress and Cash Runway
PremiumCompany Announcements
NextCure Updates ADC Pipeline Progress and Cash Runway
6M ago
8K
NXTC
NextCure expects SIM0505 Phase 1 dose escalation data update in Q2
PremiumThe Fly
NextCure expects SIM0505 Phase 1 dose escalation data update in Q2
6M ago
NXTC
Two new option listings and eighteen option delistings on December 22nd
PremiumThe FlyTwo new option listings and eighteen option delistings on December 22nd
7M ago
QD
EPS
NextCure Launches At-The-Market Stock Offering Program
Premium
Company Announcements
NextCure Launches At-The-Market Stock Offering Program
7M ago
8K
NXTC
NextCure files to sell 2.52M shares of common stock for holders
Premium
The Fly
NextCure files to sell 2.52M shares of common stock for holders
8M ago
NXTC
NextCure Raises $21.5M in Private Placement
PremiumCompany Announcements
NextCure Raises $21.5M in Private Placement
8M ago
8K
NXTC
NextCure announces closing of $21.5M PIPE financing
PremiumThe Fly
NextCure announces closing of $21.5M PIPE financing
8M ago
NXTC
Promising Advancements and Strategic Partnerships Drive Buy Rating for NextCure
PremiumRatings
Promising Advancements and Strategic Partnerships Drive Buy Rating for NextCure
8M ago
NXTC
NextCure prices 2.5M shares at $8.52 in private placement
PremiumThe Fly
NextCure prices 2.5M shares at $8.52 in private placement
8M ago
NXTC
NextCure upgraded to Buy from Neutral at Ladenburg
PremiumThe FlyNextCure upgraded to Buy from Neutral at Ladenburg
8M ago
NXTC
NextCure Advances Cancer Therapies Amid Financial Adjustments
Premium
Company Announcements
NextCure Advances Cancer Therapies Amid Financial Adjustments
8M ago
NXTC
NextCure reports Q3 EPS ($3.22), consensus ($3.98)
Premium
The Fly
NextCure reports Q3 EPS ($3.22), consensus ($3.98)
8M ago
NXTC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >